Opportunities and risks in emerging market equities
Emerging market (EM) equities have struggled in 2022 to date, as have their developed market counterparts, with no shortage of culprits behind the decline. The year has been marked by volatility amid persistently high inflation, another COVID outbreak in China and heightened geopolitical risk due to Russia’s invasion of Ukraine.
Despite the difficult times, we see potential bright spots that help solidify the case for maintaining a strategic allocation to EM equities as part of a long-term, diversified portfolio. In the analysis that follows, Nuveen’s equity team offers its perspective on current themes in EM, keys to future relative performance and a cautiously optimistic outlook for this often overlooked asset class.